Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?
CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.
Zacks Investment Research9/24/2026Positive
CAH
Cardinal Health IncNYSEHEALTHCAREMEDICAL DISTRIBUTION
Key Statistics
Market Cap
$50.99B
P/E Ratio
30.42
EPS
$7.24
Beta
0.52
52W High
$258.30
52W Low
$149.72
50-Day MA
$232.90
200-Day MA
$217.26
Dividend Yield
0.92%
Profit Margin
0.67%
Forward P/E
17.70
PEG Ratio
1.11
About Cardinal Health Inc
Cardinal Health, Inc. is an American multinational health care services company.
Fundamentals
| Revenue (TTM) | $254.25B |
| Gross Profit (TTM) | $9.77B |
| EBITDA | $4.24B |
| Operating Margin | 1.33% |
| Return on Equity | 0.00% |
| Return on Assets | 3.72% |
| Revenue/Share (TTM) | $1077.32 |
| Book Value | $-12.37 |
| Price-to-Book | 16.07 |
| Price-to-Sales (TTM) | 0.20 |
| EV/Revenue | 0.217 |
| EV/EBITDA | 15.89 |
| Quarterly Earnings Growth (YoY) | 68.80% |
| Quarterly Revenue Growth (YoY) | 5.80% |
| Shares Outstanding | $231.56M |
| Float | $232.04M |
| % Insiders | 0.28% |
| % Institutions | 91.46% |
Historical Volatility
HV 10-Day
15.76%
HV 20-Day
21.19%
HV 30-Day
21.87%
HV 60-Day
22.48%
HV Rank
25.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($270.94 target)
3
Strong Buy12
Buy3
HoldLatest News
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research9/23/2026Positive
CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?
CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.
Zacks Investment Research9/22/2026Positive
Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?
CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.
Zacks Investment Research9/22/2026Positive
Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks Investment Research9/22/2026Positive
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks Investment Research9/21/2026Positive
Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?
Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.
Zacks Investment Research9/16/2026Neutral
Cardinal Health, Inc. (CAH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Cardinal Health, Inc. (CAH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha9/14/2026Neutral
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.
Zacks Investment Research9/11/2026Positive
Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?
Cardinal (CAH) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research9/10/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CAH and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/26/2026